Appeal No. 2006-2417 Page 2
Application No. 09/200,791
The references relied upon by the examiner are:
Grey et al. (Grey) 5,380,513 Jan. 10, 1995
Raines et al. (Raines) 5,840,296 Nov. 24, 1998
(filed Oct. 15, 1997)
Behr et al. (Behr), “Reduction of the Renal Uptake of Radiolabeled Monoclonal
Antibody Fragments by Cationic Amino Acids and Their Derivatives,” Cancer
Research, Vol. 55, pp. 3825-3834 (1995)
GROUNDS OF REJECTION
Claims 1-8, 11-19, 23-28, 31-39, and 41 stand rejected under 35 U.S.C.
§ 102(b) as anticipated by Behr.
Claims 1-9, 11-21, 23-29, and 31-41 stand rejected under 35 U.S.C.
§ 103 as being unpatentable over the combination of Behr, Grey, and Raines.
We affirm.
CLAIM GROUPING
Appellants do not separately group or argue the claims on appeal.
Accordingly, the claims will stand or fall together. Since all claims stand or fall
together, we limit our discussion to representative independent claim 1.
Therefore with regard to the anticipation rejection, claims 2-8, 11-19, 23-28,
31-39, and 41 will stand or fall together with claim 1. With regard to the
obviousness rejection, claims 2-9, 11-21, 23-29, and 31-41 will stand or fall
together with claim 1. In re Young, 927 F.2d 588, 590, 18 USPQ2d 1089, 1091
(Fed. Cir. 1991).
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007